Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shelley F Stone

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Current Allergy and Asthma Reports|November 17, 2011
Mediators released during human anaphylaxisShelley F Stone, Simon G A Brown
Current HIV Research|July 29, 2004
Immune restoration disease: a consequence of dysregulated immune responses after HAARTShelley F Stone, Patricia Price, Martyn A French
AIDS (London, England)|July 29, 2004
Immune restoration disease after antiretroviral therapyMartyn A French, Patricia Price, Shelley F Stone
Clinical Immunology (Orlando, Fla.)|May 31, 2008
The number and function of circulating dendritic cells may limit effector memory CD4+ T-cell responses in HIV patients responding to antiretroviral therapySonia Fernandez, Shelley F Stone, Patricia Price, et al.
The Journal of Infectious Diseases|June 27, 2002
Cytomegalovirus (CMV) retinitis immune restoration disease occurs during highly active antiretroviral therapy-induced restoration of CMV-specific immune responses within a predominant Th2 cytokine environmentShelley F Stone, Patricia Price, Mei-Ling Tay-Kearney, et al.
AIDS (London, England)|April 2, 2005
HIV patients on antiretroviral therapy have high frequencies of CD8 T cells specific for Immediate Early protein-1 of cytomegalovirusShelley F Stone, Patricia Price, Naeem Khan, et al.
The Journal of Infectious Diseases|October 31, 2002
Association of increased hepatitis C virus (HCV)-specific IgG and soluble CD26 dipeptidyl peptidase IV enzyme activity with hepatotoxicity after highly active antiretroviral therapy in human immunodeficiency virus-HCV-coinfected patientsShelley F Stone, Silvia Lee, Niamh M Keane, et al.
The Journal of Allergy and Clinical Immunology|November 5, 2013
Reply: To PMID 23915715Simon G A Brown, Shelley F Stone, Daniel M Fatovich, et al.
The Journal of Allergy and Clinical Immunology|September 22, 2009
Elevated serum cytokines during human anaphylaxis: Identification of potential mediators of acute allergic reactionsShelley F Stone, Claire Cotterell, Geoffrey K Isbister, et al.
Current Opinion in HIV and AIDS|April 18, 2009
Monitoring clinical trials of therapeutic vaccines in HIV infection: role of treatment interruptionMichael M Lederman, Adam Penn-Nicholson, Shelley F Stone, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Current Allergy and Asthma Reports|November 17, 2011
Mediators released during human anaphylaxisShelley F Stone, Simon G A Brown
Current HIV Research|July 29, 2004
Immune restoration disease: a consequence of dysregulated immune responses after HAARTShelley F Stone, Patricia Price, Martyn A French
AIDS (London, England)|July 29, 2004
Immune restoration disease after antiretroviral therapyMartyn A French, Patricia Price, Shelley F Stone
Clinical Immunology (Orlando, Fla.)|May 31, 2008
The number and function of circulating dendritic cells may limit effector memory CD4+ T-cell responses in HIV patients responding to antiretroviral therapySonia Fernandez, Shelley F Stone, Patricia Price, et al.
The Journal of Infectious Diseases|June 27, 2002
Cytomegalovirus (CMV) retinitis immune restoration disease occurs during highly active antiretroviral therapy-induced restoration of CMV-specific immune responses within a predominant Th2 cytokine environmentShelley F Stone, Patricia Price, Mei-Ling Tay-Kearney, et al.
AIDS (London, England)|April 2, 2005
HIV patients on antiretroviral therapy have high frequencies of CD8 T cells specific for Immediate Early protein-1 of cytomegalovirusShelley F Stone, Patricia Price, Naeem Khan, et al.
The Journal of Infectious Diseases|October 31, 2002
Association of increased hepatitis C virus (HCV)-specific IgG and soluble CD26 dipeptidyl peptidase IV enzyme activity with hepatotoxicity after highly active antiretroviral therapy in human immunodeficiency virus-HCV-coinfected patientsShelley F Stone, Silvia Lee, Niamh M Keane, et al.
The Journal of Allergy and Clinical Immunology|November 5, 2013
Reply: To PMID 23915715Simon G A Brown, Shelley F Stone, Daniel M Fatovich, et al.
The Journal of Allergy and Clinical Immunology|September 22, 2009
Elevated serum cytokines during human anaphylaxis: Identification of potential mediators of acute allergic reactionsShelley F Stone, Claire Cotterell, Geoffrey K Isbister, et al.
Current Opinion in HIV and AIDS|April 18, 2009
Monitoring clinical trials of therapeutic vaccines in HIV infection: role of treatment interruptionMichael M Lederman, Adam Penn-Nicholson, Shelley F Stone, et al.
Pageof 3